FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3002857093> ?p ?o ?g. }

• W3002857093 endingPage "45" @default.
• W3002857093 startingPage "35" @default.
• W3002857093 abstract "Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders. The main causes of NAFLD are associated with insulin resistance, severe lipid metabolism disorders, oxidative stress and inflammation. Previous studies have reported that ginger has positive metabolic results.The aim of this study was to determine the effect of ginger powder supplement on lipid profiles, insulin resistance, liver enzymes, inflammatory cytokines and antioxidant status in patients with NAFLD.In this randomized clinical trial, 46 people with NAFLD were parted into two groups and subjected to the ginger or placebo capsules (3 capsules daily, each containing 500 mg of ginger or wheat flour) over 12 weeks. All patients received a diet with balanced energy and physical activity during the intervention period. Liver ultrasonography, anthropometric indices and biochemical parameters were measured before and after intervention.No significant difference was found between the two groups in the baseline variables at the beginning of the study. At the end of the study, serum levels of alanine aminotransferase (ALT), total cholesterol, low-density lipoprotein (LDL-C), fasting blood glucose, and insulin resistance index (HOMA), C-reactive protein (hs-CRP), and fetuin-A in the group receiving a ginger supplement significantly decreased compared to placebo. However, there was no significant difference between the two groups in body weight, fasting insulin, HDL-C, triglyceride, adiponectin, alpha-tumor necrosis factor (TNF-α), total antioxidant capacity (TAC), gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), fatty liver index (FLI), fatty liver grade and blood pressure.The ginger supplement may be used as a complementary therapy along with existing therapies to reduce insulin resistance, liver enzymes and inflammation in patients with non-alcoholic fatty liver." @default.
• W3002857093 created "2020-01-30" @default.
• W3002857093 creator A5032258207 @default.
• W3002857093 creator A5044141980 @default.
• W3002857093 creator A5046074448 @default.
• W3002857093 creator A5085278966 @default.
• W3002857093 creator A5087522337 @default.
• W3002857093 date "2020-01-01" @default.
• W3002857093 modified "2023-10-17" @default.
• W3002857093 title "<p>Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial</p>" @default.
• W3002857093 cites W1746025684 @default.
• W3002857093 cites W1906471923 @default.
• W3002857093 cites W1912046403 @default.
• W3002857093 cites W1963683487 @default.
• W3002857093 cites W1981714984 @default.
• W3002857093 cites W1984669204 @default.
• W3002857093 cites W2003192906 @default.
• W3002857093 cites W2004296095 @default.
• W3002857093 cites W2015275823 @default.
• W3002857093 cites W2016617561 @default.
• W3002857093 cites W2019048359 @default.
• W3002857093 cites W2021792414 @default.
• W3002857093 cites W2021950225 @default.
• W3002857093 cites W2030517991 @default.
• W3002857093 cites W2035267325 @default.
• W3002857093 cites W2040435503 @default.
• W3002857093 cites W2049624461 @default.
• W3002857093 cites W2052763780 @default.
• W3002857093 cites W2056696616 @default.
• W3002857093 cites W2060405968 @default.
• W3002857093 cites W2103156933 @default.
• W3002857093 cites W2108036255 @default.
• W3002857093 cites W2116460737 @default.
• W3002857093 cites W2125001488 @default.
• W3002857093 cites W2130233981 @default.
• W3002857093 cites W2142517328 @default.
• W3002857093 cites W2144178804 @default.
• W3002857093 cites W2144219474 @default.
• W3002857093 cites W2158163588 @default.
• W3002857093 cites W2159266126 @default.
• W3002857093 cites W2164118055 @default.
• W3002857093 cites W2222010873 @default.
• W3002857093 cites W2305245706 @default.
• W3002857093 cites W2324806662 @default.
• W3002857093 cites W2396088323 @default.
• W3002857093 cites W2769510851 @default.
• W3002857093 cites W2900051103 @default.
• W3002857093 cites W2941998281 @default.
• W3002857093 cites W2954744445 @default.
• W3002857093 doi "https://doi.org/10.2147/ceg.s234698" @default.
• W3002857093 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6986243" @default.
• W3002857093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32158249" @default.
• W3002857093 hasPublicationYear "2020" @default.
• W3002857093 type Work @default.
• W3002857093 sameAs 3002857093 @default.
• W3002857093 citedByCount "25" @default.
• W3002857093 countsByYear W30028570932020 @default.
• W3002857093 countsByYear W30028570932021 @default.
• W3002857093 countsByYear W30028570932022 @default.
• W3002857093 countsByYear W30028570932023 @default.
• W3002857093 crossrefType "journal-article" @default.
• W3002857093 hasAuthorship W3002857093A5032258207 @default.
• W3002857093 hasAuthorship W3002857093A5044141980 @default.
• W3002857093 hasAuthorship W3002857093A5046074448 @default.
• W3002857093 hasAuthorship W3002857093A5085278966 @default.
• W3002857093 hasAuthorship W3002857093A5087522337 @default.
• W3002857093 hasBestOaLocation W30028570931 @default.
• W3002857093 hasConcept C126322002 @default.
• W3002857093 hasConcept C134018914 @default.
• W3002857093 hasConcept C139572402 @default.
• W3002857093 hasConcept C142724271 @default.
• W3002857093 hasConcept C204787440 @default.
• W3002857093 hasConcept C27081682 @default.
• W3002857093 hasConcept C2776782570 @default.
• W3002857093 hasConcept C2777391703 @default.
• W3002857093 hasConcept C2778163477 @default.
• W3002857093 hasConcept C2778270857 @default.
• W3002857093 hasConcept C2778772119 @default.
• W3002857093 hasConcept C2778913445 @default.
• W3002857093 hasConcept C2779134260 @default.
• W3002857093 hasConcept C2779306644 @default.
• W3002857093 hasConcept C71924100 @default.
• W3002857093 hasConcept C90924648 @default.
• W3002857093 hasConceptScore W3002857093C126322002 @default.
• W3002857093 hasConceptScore W3002857093C134018914 @default.
• W3002857093 hasConceptScore W3002857093C139572402 @default.
• W3002857093 hasConceptScore W3002857093C142724271 @default.
• W3002857093 hasConceptScore W3002857093C204787440 @default.
• W3002857093 hasConceptScore W3002857093C27081682 @default.
• W3002857093 hasConceptScore W3002857093C2776782570 @default.
• W3002857093 hasConceptScore W3002857093C2777391703 @default.
• W3002857093 hasConceptScore W3002857093C2778163477 @default.
• W3002857093 hasConceptScore W3002857093C2778270857 @default.
• W3002857093 hasConceptScore W3002857093C2778772119 @default.
• W3002857093 hasConceptScore W3002857093C2778913445 @default.
• W3002857093 hasConceptScore W3002857093C2779134260 @default.
• W3002857093 hasConceptScore W3002857093C2779306644 @default.
• W3002857093 hasConceptScore W3002857093C71924100 @default.

• next